SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000913414-07-002008
Filing Date
2007-01-23
Accepted
2007-01-23 16:36:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 npspharm123106.txt SC 13G 23567
  Complete submission text file 0000913414-07-002008.txt   25805
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44877 | Film No.: 07546976
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 45 FREMONT ST SAN FRANCISCO CA 94105
Business Address 45 FREMONT ST 17TH FL SAN FRANCISCO CA 94105 4155972639
BARCLAYS GLOBAL INVESTORS NA /CA/ (Filed by) CIK: 0000913414 (see all company filings)

IRS No.: 943112180 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000